Global and United States SGLT2 Inhibitor Market Report & Forecast 2022-2028
Table of Contents1 Study Coverage
1.1 SGLT2 Inhibitor Product Introduction
1.2 Global SGLT2 Inhibitor Outlook 2017 VS 2022 VS 2028
1.2.1 Global SGLT2 Inhibitor Sales in US$ Million for the Year 2017-2028
1.2.2 Global SGLT2 Inhibitor Sales in Volume for the Year 2017-2028
1.3 United States SGLT2 Inhibitor Outlook 2017 VS 2022 VS 2028
1.3.1 United States SGLT2 Inhibitor Sales in US$ Million for the Year 2017-2028
1.3.2 United States SGLT2 Inhibitor Sales in Volume for the Year 2017-2028
1.4 SGLT2 Inhibitor Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States SGLT2 Inhibitor in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of SGLT2 Inhibitor Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 SGLT2 Inhibitor Market Dynamics
1.5.1 SGLT2 Inhibitor Industry Trends
1.5.2 SGLT2 Inhibitor Market Drivers
1.5.3 SGLT2 Inhibitor Market Challenges
1.5.4 SGLT2 Inhibitor Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 SGLT2 Inhibitor Market Segment by Type
2.1.1 Dapagliflozin
2.1.2 Canagliflozin
2.1.3 Empagliflozin
2.1.4 Other
2.2 Global SGLT2 Inhibitor Market Size by Type
2.2.1 Global SGLT2 Inhibitor Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global SGLT2 Inhibitor Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global SGLT2 Inhibitor Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States SGLT2 Inhibitor Market Size by Type
2.3.1 United States SGLT2 Inhibitor Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States SGLT2 Inhibitor Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States SGLT2 Inhibitor Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 SGLT2 Inhibitor Market Segment by Application
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.2 Global SGLT2 Inhibitor Market Size by Application
3.2.1 Global SGLT2 Inhibitor Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global SGLT2 Inhibitor Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global SGLT2 Inhibitor Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States SGLT2 Inhibitor Market Size by Application
3.3.1 United States SGLT2 Inhibitor Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States SGLT2 Inhibitor Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States SGLT2 Inhibitor Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global SGLT2 Inhibitor Competitor Landscape by Company
4.1 Global SGLT2 Inhibitor Market Size by Company
4.1.1 Top Global SGLT2 Inhibitor Manufacturers Ranked by Revenue (2021)
4.1.2 Global SGLT2 Inhibitor Revenue by Manufacturer (2017-2022)
4.1.3 Global SGLT2 Inhibitor Sales by Manufacturer (2017-2022)
4.1.4 Global SGLT2 Inhibitor Price by Manufacturer (2017-2022)
4.2 Global SGLT2 Inhibitor Concentration Ratio (CR)
4.2.1 SGLT2 Inhibitor Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of SGLT2 Inhibitor in 2021
4.2.3 Global SGLT2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global SGLT2 Inhibitor Manufacturing Base Distribution, Product Type
4.3.1 Global SGLT2 Inhibitor Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers SGLT2 Inhibitor Product Type
4.3.3 Date of International Manufacturers Enter into SGLT2 Inhibitor Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States SGLT2 Inhibitor Market Size by Company
4.5.1 Top SGLT2 Inhibitor Players in United States, Ranked by Revenue (2021)
4.5.2 United States SGLT2 Inhibitor Revenue by Players (2020, 2021 & 2022)
4.5.3 United States SGLT2 Inhibitor Sales by Players (2020, 2021 & 2022)
5 Global SGLT2 Inhibitor Market Size by Region
5.1 Global SGLT2 Inhibitor Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global SGLT2 Inhibitor Market Size in Volume by Region (2017-2028)
5.2.1 Global SGLT2 Inhibitor Sales in Volume by Region: 2017-2022
5.2.2 Global SGLT2 Inhibitor Sales in Volume Forecast by Region (2023-2028)
5.3 Global SGLT2 Inhibitor Market Size in Value by Region (2017-2028)
5.3.1 Global SGLT2 Inhibitor Sales in Value by Region: 2017-2022
5.3.2 Global SGLT2 Inhibitor Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America SGLT2 Inhibitor Market Size YoY Growth 2017-2028
6.1.2 North America SGLT2 Inhibitor Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific SGLT2 Inhibitor Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific SGLT2 Inhibitor Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe SGLT2 Inhibitor Market Size YoY Growth 2017-2028
6.3.2 Europe SGLT2 Inhibitor Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America SGLT2 Inhibitor Market Size YoY Growth 2017-2028
6.4.2 Latin America SGLT2 Inhibitor Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa SGLT2 Inhibitor Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa SGLT2 Inhibitor Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporation Information
7.1.2 Eli Lilly Description and Business Overview
7.1.3 Eli Lilly SGLT2 Inhibitor Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Eli Lilly SGLT2 Inhibitor Products Offered
7.1.5 Eli Lilly Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Corporation Information
7.2.2 Boehringer Ingelheim Description and Business Overview
7.2.3 Boehringer Ingelheim SGLT2 Inhibitor Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Boehringer Ingelheim SGLT2 Inhibitor Products Offered
7.2.5 Boehringer Ingelheim Recent Development
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporation Information
7.3.2 Johnson & Johnson Description and Business Overview
7.3.3 Johnson & Johnson SGLT2 Inhibitor Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Johnson & Johnson SGLT2 Inhibitor Products Offered
7.3.5 Johnson & Johnson Recent Development
7.4 AstraZeneca
7.4.1 AstraZeneca Corporation Information
7.4.2 AstraZeneca Description and Business Overview
7.4.3 AstraZeneca SGLT2 Inhibitor Sales, Revenue and Gross Margin (2017-2022)
7.4.4 AstraZeneca SGLT2 Inhibitor Products Offered
7.4.5 AstraZeneca Recent Development
7.5 Merck
7.5.1 Merck Corporation Information
7.5.2 Merck Description and Business Overview
7.5.3 Merck SGLT2 Inhibitor Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Merck SGLT2 Inhibitor Products Offered
7.5.5 Merck Recent Development
7.6 Pfizer
7.6.1 Pfizer Corporation Information
7.6.2 Pfizer Description and Business Overview
7.6.3 Pfizer SGLT2 Inhibitor Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Pfizer SGLT2 Inhibitor Products Offered
7.6.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 SGLT2 Inhibitor Industry Chain Analysis
8.2 SGLT2 Inhibitor Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 SGLT2 Inhibitor Distributors
8.3 SGLT2 Inhibitor Production Mode & Process
8.4 SGLT2 Inhibitor Sales and Marketing
8.4.1 SGLT2 Inhibitor Sales Channels
8.4.2 SGLT2 Inhibitor Distributors
8.5 SGLT2 Inhibitor Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of TablesTable 1. SGLT2 Inhibitor CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. SGLT2 Inhibitor Market Trends
Table 3. SGLT2 Inhibitor Market Drivers
Table 4. SGLT2 Inhibitor Market Challenges
Table 5. SGLT2 Inhibitor Market Restraints
Table 6. Global SGLT2 Inhibitor Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States SGLT2 Inhibitor Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global SGLT2 Inhibitor Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States SGLT2 Inhibitor Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top SGLT2 Inhibitor Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global SGLT2 Inhibitor Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global SGLT2 Inhibitor Revenue Share by Manufacturer, 2017-2022
Table 13. Global SGLT2 Inhibitor Sales by Manufacturer, (Kg), 2017-2022
Table 14. Global SGLT2 Inhibitor Sales Share by Manufacturer, 2017-2022
Table 15. Global SGLT2 Inhibitor Price by Manufacturer (2017-2022) & (USD/g)
Table 16. Global SGLT2 Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global SGLT2 Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in SGLT2 Inhibitor as of 2021)
Table 18. Top Players of SGLT2 Inhibitor in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers SGLT2 Inhibitor Product Type
Table 20. Date of International Manufacturers Enter into SGLT2 Inhibitor Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top SGLT2 Inhibitor Players in United States Market, Ranking by Revenue (2021)
Table 23. United States SGLT2 Inhibitor Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States SGLT2 Inhibitor Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States SGLT2 Inhibitor Sales by Players, (Kg), 2020, 2021 & 2022
Table 26. United States SGLT2 Inhibitor Sales Share by Players, 2020, 2021 & 2022
Table 27. Global SGLT2 Inhibitor Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global SGLT2 Inhibitor Sales in Volume by Region (2017-2022) & (Kg)
Table 29. Global SGLT2 Inhibitor Sales in Volume Forecast by Region (2023-2028) & (Kg)
Table 30. Global SGLT2 Inhibitor Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global SGLT2 Inhibitor Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
Table 33. North America SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific SGLT2 Inhibitor Sales in Volume by Region (2017-2028) & (Kg)
Table 35. Asia Pacific SGLT2 Inhibitor Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
Table 37. Europe SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
Table 39. Latin Americaa SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa SGLT2 Inhibitor Sales in Volume by Country (2017-2028) & (Kg)
Table 41. Middle East and Africa SGLT2 Inhibitor Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Eli Lilly Corporation Information
Table 43. Eli Lilly Description and Business Overview
Table 44. Eli Lilly SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 45. Eli Lilly SGLT2 Inhibitor Product
Table 46. Eli Lilly Recent Development
Table 47. Boehringer Ingelheim Corporation Information
Table 48. Boehringer Ingelheim Description and Business Overview
Table 49. Boehringer Ingelheim SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 50. Boehringer Ingelheim Product
Table 51. Boehringer Ingelheim Recent Development
Table 52. Johnson & Johnson Corporation Information
Table 53. Johnson & Johnson Description and Business Overview
Table 54. Johnson & Johnson SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 55. Johnson & Johnson Product
Table 56. Johnson & Johnson Recent Development
Table 57. AstraZeneca Corporation Information
Table 58. AstraZeneca Description and Business Overview
Table 59. AstraZeneca SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 60. AstraZeneca Product
Table 61. AstraZeneca Recent Development
Table 62. Merck Corporation Information
Table 63. Merck Description and Business Overview
Table 64. Merck SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 65. Merck Product
Table 66. Merck Recent Development
Table 67. Pfizer Corporation Information
Table 68. Pfizer Description and Business Overview
Table 69. Pfizer SGLT2 Inhibitor Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 70. Pfizer Product
Table 71. Pfizer Recent Development
Table 72. Key Raw Materials Lists
Table 73. Raw Materials Key Suppliers Lists
Table 74. SGLT2 Inhibitor Customers List
Table 75. SGLT2 Inhibitor Distributors List
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of FiguresFigure 1. SGLT2 Inhibitor Product Picture
Figure 2. Global SGLT2 Inhibitor Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global SGLT2 Inhibitor Market Size 2017-2028 (US$ Million)
Figure 4. Global SGLT2 Inhibitor Sales 2017-2028 (Kg)
Figure 5. United States SGLT2 Inhibitor Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States SGLT2 Inhibitor Market Size 2017-2028 (US$ Million)
Figure 7. United States SGLT2 Inhibitor Sales 2017-2028 (Kg)
Figure 8. United States SGLT2 Inhibitor Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States SGLT2 Inhibitor Market Share in Global, in Volume (Kg) 2017-2028
Figure 10. SGLT2 Inhibitor Report Years Considered
Figure 11. Product Picture of Dapagliflozin
Figure 12. Product Picture of Canagliflozin
Figure 13. Product Picture of Empagliflozin
Figure 14. Product Picture of Other
Figure 15. Global SGLT2 Inhibitor Market Share by Type in 2022 & 2028
Figure 16. Global SGLT2 Inhibitor Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global SGLT2 Inhibitor Sales Market Share in Value by Type (2017-2028)
Figure 18. Global SGLT2 Inhibitor Sales by Type (2017-2028) & (Kg)
Figure 19. Global SGLT2 Inhibitor Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global SGLT2 Inhibitor Price by Type (2017-2028) & (USD/g)
Figure 21. United States SGLT2 Inhibitor Market Share by Type in 2022 & 2028
Figure 22. United States SGLT2 Inhibitor Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States SGLT2 Inhibitor Sales Market Share in Value by Type (2017-2028)
Figure 24. United States SGLT2 Inhibitor Sales by Type (2017-2028) & (Kg)
Figure 25. United States SGLT2 Inhibitor Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States SGLT2 Inhibitor Price by Type (2017-2028) & (USD/g)
Figure 27. Product Picture of Hospital Pharmacies
Figure 28. Product Picture of Retail Pharmacies
Figure 29. Global SGLT2 Inhibitor Market Share by Application in 2022 & 2028
Figure 30. Global SGLT2 Inhibitor Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global SGLT2 Inhibitor Sales Market Share in Value by Application (2017-2028)
Figure 32. Global SGLT2 Inhibitor Sales by Application (2017-2028) & (Kg)
Figure 33. Global SGLT2 Inhibitor Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global SGLT2 Inhibitor Price by Application (2017-2028) & (USD/g)
Figure 35. United States SGLT2 Inhibitor Market Share by Application in 2022 & 2028
Figure 36. United States SGLT2 Inhibitor Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States SGLT2 Inhibitor Sales Market Share in Value by Application (2017-2028)
Figure 38. United States SGLT2 Inhibitor Sales by Application (2017-2028) & (Kg)
Figure 39. United States SGLT2 Inhibitor Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States SGLT2 Inhibitor Price by Application (2017-2028) & (USD/g)
Figure 41. North America SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 42. North America SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 46. Europe SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 53. Asia-Pacific SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 65. Latin America SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa SGLT2 Inhibitor Sales in Volume Growth Rate 2017-2028 (Kg)
Figure 70. Middle East & Africa SGLT2 Inhibitor Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E SGLT2 Inhibitor Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. SGLT2 Inhibitor Value Chain
Figure 75. SGLT2 Inhibitor Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed